Powder: -20°C for 3 years | In solvent: -80°C for 1 year
13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. It inhibits the ADP-induced aggregation of human platelets with an ED50 of about 40 nM in PRP and 77 nM in washed platelets, which is comparable to the potency of carbaprostacyclin.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 μg | 35 days | $ 155.00 | |
100 μg | 35 days | $ 288.00 | |
500 μg | 35 days | $ 1,190.00 |
Description | 13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. It inhibits the ADP-induced aggregation of human platelets with an ED50 of about 40 nM in PRP and 77 nM in washed platelets, which is comparable to the potency of carbaprostacyclin. |
Molecular Weight | 346.467 |
Formula | C21H30O4 |
CAS No. | 145375-81-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMF: >10 mg/mL (from 6B-PGI2)
DMSO: >5 mg/mL (from 6B-PGI2)
PBS (pH 7.2): >80 mg/mL (from 6B-PGI2)
Ethanol: >20 mg/mL (from 6B-PGI2)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
13,14-dehydro-15-cyclohexyl Carbaprostacyclin 145375-81-1 13,14dehydro15cyclohexyl Carbaprostacyclin 13,14 dehydro 15 cyclohexyl Carbaprostacyclin inhibitor inhibit